Speaking to politykazdrowotna.pl, Prof. Piotr H. Skarżyński highlighted innovative approaches to hearing therapy using microRNA (miRNA). According to the Professor, these short, non-coding RNA molecules could play a key role in restoring hearing in the future.
‘It is estimated that around 30 per cent of human genes are controlled by microRNAs, which regulate gene expression by binding to regions of messenger RNA (mRNA),’ explains Prof. Skarżyński.
He adds that miRNA is responsible for cell differentiation and function in the inner ear, and disturbances in its expression may contribute to hearing problems.
Although there are currently no miRNA-based therapies that effectively treat deafness caused by hair cell damage, Prof. Skarżyński stresses that cochlear implants are currently the best treatment for this type of condition.
The full interview: here.